[{"_1":2,"_429":-5,"_430":-5},"loaderData",{"_3":4,"_11":12},"root",{"_5":6,"_7":8,"_9":10},"theme",0,"baseURL","https://pocketcasts.com","locale","en","routes/_app.podcast.$podcastSlug.$podcastUuid.$episodeSlug.$episodeUuid",{"_13":14,"_15":16,"_17":18},"podcastUuid","0d324d20-779a-0138-ede8-0acc26574db2","episodeUuid","153652b3-b08a-43b3-9999-1d6665650485","dehydratedState",{"_19":20,"_21":22},"mutations",[],"queries",[23,423],{"_24":25,"_26":27,"_417":418,"_421":422},"dehydratedAt",1771949385082,"state",{"_28":29,"_402":403,"_404":405,"_406":-5,"_407":6,"_408":6,"_409":6,"_410":-5,"_411":-5,"_412":35,"_413":414,"_415":416},"data",{"_30":31,"_32":33,"_34":35,"_36":6,"_37":38,"_39":35,"_40":41},"episode_frequency","Unknown","estimated_next_episode_at","2026-03-05T15:00:00Z","has_seasons",false,"season_count","episode_count",41,"has_more_episodes","podcast",{"_42":43,"_44":45,"_46":47,"_48":49,"_50":51,"_52":51,"_53":54,"_55":56,"_57":58,"_59":14,"_60":61,"_62":63,"_64":35,"_65":56,"_66":67},"url","https://jamanetwork.com/journals/jama/pages/jamaevidence-jama-guide-to-statistics-and-methods","title","JAMAevidence JAMA Guide to Statistics and Methods","slug","jamaevidence-jama-guide-to-statistics-and-methods","author","JAMA Network","description","Interviews with authors of JAMA Guide to Statistics and Methods chapters about common and new statistics and methods used in clinical research and reported in medical journals.","description_html","category","Health & Fitness\n Medicine\nScience","audio",true,"show_type","episodic","uuid","fundings",[],"guid","","is_private","transcript_eligible","episodes",[68,83,91,98,106,114,122,130,138,146,154,162,170,178,186,194,202,210,218,226,234,242,250,258,266,274,282,290,298,306,314,322,330,338,346,354,362,370,378,386,394],{"_59":69,"_44":70,"_46":71,"_42":72,"_73":74,"_75":76,"_77":78,"_79":80,"_81":82},"262dd066-28f9-4001-bddc-793d2e2c390d","Tipping Point Analysis: Assessing the Potential Impact of Missing Data With Dr Sims","tipping-point-analysis-assessing-the-potential-impact-of-missing-data-with-dr-sims","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Tipping_Point_Analysis_Assessing_the_Potential_Impact_of_Missing_Data_With_Dr_Sims.mp3?dest-id=1862984","file_type","audio/mpeg","file_size",24101945,"duration",601,"published","2026-01-08T16:00:00Z","type","full",{"_59":84,"_44":85,"_46":86,"_42":87,"_73":74,"_75":88,"_77":89,"_79":90,"_81":82},"d82fa25c-73b3-4a28-8427-b4c95b93e378","Instrumental Variables and Heterogeneous Treatment Effects With Dr Norton","instrumental-variables-and-heterogeneous-treatment-effects-with-dr-norton","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/University_of_Michigan_Health_Management_and_Policy_With__Dr_Norton.mp3?dest-id=1862984",44182628,1103,"2025-09-04T15:00:00Z",{"_59":16,"_44":92,"_46":93,"_42":94,"_73":74,"_75":95,"_77":96,"_79":97,"_81":82},"Factorial Clinical Trial Designs With Dr Ciolino","factorial-clinical-trial-designs-with-dr-ciolino","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Factorial_Clinical_Trial_Designs_With_Dr_Ciolino.mp3?dest-id=1862984",45960472,1147,"2025-08-07T15:00:00Z",{"_59":99,"_44":100,"_46":101,"_42":102,"_73":74,"_75":103,"_77":104,"_79":105,"_81":82},"ae6eb0dc-4f9e-4e86-85d0-8e7dedeff914","JAMA Guide to Statistics and Methods: Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis With Professor Brooks","jama-guide-to-statistics-and-methods-assessing-unexpected-circumstances-that-lead-to-modifications-in-clinical-trial-design-conduct-or-analysis-with-professor-brooks","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/JAMA_Guide_to_Statistics_and_Methods_Assessing_Unexpected_Circumstances_That_Lead_to_Modifications_in_Clinical_Trial_Design_Conduct_or_Analysis_With_Professor_Brooks.mp3?dest-id=1862984",40234587,1004,"2025-07-03T15:00:00Z",{"_59":107,"_44":108,"_46":109,"_42":110,"_73":74,"_75":111,"_77":112,"_79":113,"_81":82},"9754ae0f-2eef-43a7-821b-57f2c3099094","JAMA Guide to Statistics and Methods: Collider Bias With Dr Andersen","jama-guide-to-statistics-and-methods-collider-bias-with-dr-andersen","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/JAMA_Guide_to_Statistics_and_Methods_Collider_Bias_With_Dr_Andersen.mp3?dest-id=1862984",46704542,1166,"2025-06-05T15:00:00Z",{"_59":115,"_44":116,"_46":117,"_42":118,"_73":74,"_75":119,"_77":120,"_79":121,"_81":82},"f7a47516-28ad-4475-bb99-7a6459796f55","Nonparametric Statistical Analysis With Dr Lachin","nonparametric-statistical-analysis-with-dr-lachin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Nonparametric_Statistical_Analysis_With_Dr_Lachin.mp3?dest-id=1862984",28734234,716,"2025-04-03T15:00:00Z",{"_59":123,"_44":124,"_46":125,"_42":126,"_73":74,"_75":127,"_77":128,"_79":129,"_81":82},"b2a92152-94a0-4503-b086-811f23f672b2","The Use of Historical Controls in Clinical Trials, With Dr Althouse","the-use-of-historical-controls-in-clinical-trials-with-dr-althouse","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/The_Use_of_Historical_Controls_in_Clinical_Trials_With_Dr_Althouse.mp3?dest-id=1862984",49877349,1245,"2025-02-06T16:00:00Z",{"_59":131,"_44":132,"_46":133,"_42":134,"_73":74,"_75":135,"_77":136,"_79":137,"_81":82},"42ca7e35-8c95-4c92-a615-396fd2dd802d","Futility in Clinical Trials With Dr Wendelberger","futility-in-clinical-trials-with-dr-wendelberger","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Futility_in_Clinical_Trials_With_Dr_Wendelberger.mp3?dest-id=1862984",36467924,910,"2024-12-05T16:00:00Z",{"_59":139,"_44":140,"_46":141,"_42":142,"_73":74,"_75":143,"_77":144,"_79":145,"_81":82},"580ecd81-bbb8-4f07-86c5-18c3bdb1153b","Interim Analyses During Group Sequential Trials With Dr Meurer","interim-analyses-during-group-sequential-trials-with-dr-meurer","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Interim_Analyses_During_Group_Sequential_Trials_With_Dr_Meurer.mp3?dest-id=1862984",39052369,974,"2024-11-07T16:00:00Z",{"_59":147,"_44":148,"_46":149,"_42":150,"_73":74,"_75":151,"_77":152,"_79":153,"_81":82},"5c0cdfcb-45ac-45f1-b00d-ea43e0cc3b9a","Genome-Wide Association Studies With Dr Rotter","genome-wide-association-studies-with-dr-rotter","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Genome-Wide_Association_Studies_With_Dr_Rotter.mp3?dest-id=1862984",56321966,1406,"2024-09-05T15:00:00Z",{"_59":155,"_44":156,"_46":157,"_42":158,"_73":74,"_75":159,"_77":160,"_79":161,"_81":82},"5861237c-96fd-4b4c-95b0-6c70197af72f","Conditional Power: How Likely Is Trial Success?","conditional-power-how-likely-is-trial-success","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Conditional_Power_How_Likely_Is_Trial_Success.mp3?dest-id=1862984",39607273,988,"2024-08-01T16:45:00Z",{"_59":163,"_44":164,"_46":165,"_42":166,"_73":74,"_75":167,"_77":168,"_79":169,"_81":82},"8945d27e-5a32-4271-8f5d-1fd79496f7ad","Bayesian Hierarchical Models With Dr McGlothlin","bayesian-hierarchical-models-with-dr-mcglothlin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Bayesian_Hierarchical_Models_With_Dr_McGlothlin.mp3?dest-id=1862984",36349850,907,"2024-07-03T15:00:00Z",{"_59":171,"_44":172,"_46":173,"_42":174,"_73":74,"_75":175,"_77":176,"_79":177,"_81":82},"027d0fe4-9c22-41f0-b21a-4f3ca216243e","Sequential, Multiple Assignment, Randomized Trial Designs With Dr Kidwell","sequential-multiple-assignment-randomized-trial-designs-with-dr-kidwell","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Sequential_Multiple_Assignment_Randomized_Trial_Designs_With_Dr_Kidwell.mp3?dest-id=1862984",32359288,807,"2024-06-06T15:00:00Z",{"_59":179,"_44":180,"_46":181,"_42":182,"_73":74,"_75":183,"_77":184,"_79":185,"_81":82},"13d5ad3e-2225-4668-9f76-b45f47d8f89d","Target Trial Emulation for Causal Inference From Observational Data With Dr Hernán","target-trial-emulation-for-causal-inference-from-observational-data-with-dr-hernán","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Target_Trial_Emulation_for_Causal_Inference_From_Observational_Data_With_Dr_Hernn.mp3?dest-id=1862984",65868219,1645,"2024-05-02T15:00:00Z",{"_59":187,"_44":188,"_46":189,"_42":190,"_73":74,"_75":191,"_77":192,"_79":193,"_81":82},"7212e2ec-7143-4e83-b919-730863516f7a","On Deep Learning for Medical Image Analysis With Dr Carin","on-deep-learning-for-medical-image-analysis-with-dr-carin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/On_Deep_Learning_for_Medical_Image_Analysis_With_Dr_Carin.mp3?dest-id=1862984",55056404,1374,"2024-04-04T15:00:00Z",{"_59":195,"_44":196,"_46":197,"_42":198,"_73":74,"_75":199,"_77":200,"_79":201,"_81":82},"42a76818-3d20-4336-bba5-4bc065ed870e","Patient-Reported Outcome Measures in Clinical Research With Drs Weinfurt and Reeve","patient-reported-outcome-measures-in-clinical-research-with-drs-weinfurt-and-reeve","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Patient-Reported_Outcome_Measures_in_Clinical_Research_With_Drs_Weinfurt_and_Reeve.mp3?dest-id=1862984",53272353,1330,"2024-03-07T16:00:00Z",{"_59":203,"_44":204,"_46":205,"_42":206,"_73":74,"_75":207,"_77":208,"_79":209,"_81":82},"445454f3-49be-41fb-a2c6-7f907084cc6f","Immortal Time Bias in Observational Studies With Dr Kabir Yadav","immortal-time-bias-in-observational-studies-with-dr-kabir-yadav","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Immortal_Time_Bias_in_Observational_Studies_With_Dr_Kabir_Yadav.mp3?dest-id=1862984",36329367,906,"2024-01-04T16:00:00Z",{"_59":211,"_44":212,"_46":213,"_42":214,"_73":74,"_75":215,"_77":216,"_79":217,"_81":82},"a168523e-2d07-4859-bf07-b3a4f161812d","Adjustment for Baseline Characteristics in Randomized Clinical Trials","adjustment-for-baseline-characteristics-in-randomized-clinical-trials","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Adjustment_for_Baseline_Characteristics_in_Randomized_Clinical_Trials.mp3?dest-id=1862984",43866752,1095,"2023-12-07T16:00:00Z",{"_59":219,"_44":220,"_46":221,"_42":222,"_73":74,"_75":223,"_77":224,"_79":225,"_81":82},"83965a2c-7649-4d8d-bc67-e1e82be01e31","Odds Ratios—Current Best Practice and Use With Dr Norton","odds-ratioscurrent-best-practice-and-use-with-dr-norton","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Odds_Ratios_Current_Best_Practice_and_Use_With_Dr_Norton.mp3?dest-id=1862984",29625081,739,"2023-11-02T15:00:00Z",{"_59":227,"_44":228,"_46":229,"_42":230,"_73":74,"_75":231,"_77":232,"_79":233,"_81":82},"2e5832cf-973f-4b6c-bb6e-f44c0e93935b","Estimands, Estimators, and Estimates With Dr Little","estimands-estimators-and-estimates-with-dr-little","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Estimands_Estimators_and_Estimates_With_Dr_Little.mp3?dest-id=1862984",53106267,1326,"2023-08-03T15:00:00Z",{"_59":235,"_44":236,"_46":237,"_42":238,"_73":74,"_75":239,"_77":240,"_79":241,"_81":82},"bff642b3-e981-4991-9f23-b6392aca148f","Interpreting the Results of Intention-to-Treat, Per-Protocol, and As-Treated Analyses With Dr Smith","interpreting-the-results-of-intention-to-treat-per-protocol-and-as-treated-analyses-with-dr-smith","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Interpreting_the_Results_of_Intention-to-Treat_Per-Protocol_and_As-Treated_Analyses_With_Dr_Smith.mp3?dest-id=1862984",17769640,1105,"2023-05-04T15:00:00Z",{"_59":243,"_44":244,"_46":245,"_42":246,"_73":74,"_75":247,"_77":248,"_79":249,"_81":82},"ec84f874-0bfe-4933-ae64-efd81417e54e","Time-to-Event Analysis With Dr Tolles","time-to-event-analysis-with-dr-tolles","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Time-to-Event_Analysis_With_Dr_Tolles.mp3?dest-id=1862984",27248466,679,"2023-03-03T19:11:00Z",{"_59":251,"_44":252,"_46":253,"_42":254,"_73":74,"_75":255,"_77":256,"_79":257,"_81":82},"9e8dda0e-1833-4925-be74-f8313e94bb02","Adjusting for Nonadherence or Stopping Treatments With Drs Adler and Latimer","adjusting-for-nonadherence-or-stopping-treatments-with-drs-adler-and-latimer","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Adjusting_for_Nonadherence_or_Stopping_Treatments_With_Drs_Adler_and_Latimer.mp3?dest-id=1862984",17337199,1078,"2023-01-05T16:00:00Z",{"_59":259,"_44":260,"_46":261,"_42":262,"_73":74,"_75":263,"_77":264,"_79":265,"_81":82},"07a4692a-aeb0-4527-a70f-ee6665809e5b","Worst-Rank Score Methods—A Nonparametric Approach to Informatively Missing Data With Dr Lachin","worst-rank-score-methodsa-nonparametric-approach-to-informatively-missing-data-with-dr-lachin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Worst-Rank_Score_Methods_A_Nonparametric_Approach_to_Informatively_Missing_Data_With_Dr_Lachin.mp3?dest-id=1862984",41007404,1026,"2022-11-03T15:00:00Z",{"_59":267,"_44":268,"_46":269,"_42":270,"_73":74,"_75":271,"_77":272,"_79":273,"_81":82},"540aded3-cd57-4ccf-a1ab-561c994e706b","Using Latent Class Analysis to Identify Hidden Clinical Phenotypes With Dr Heather G. Allore","using-latent-class-analysis-to-identify-hidden-clinical-phenotypes-with-dr-heather-g-allore","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Using_Latent_Class_Analysis_to_Identify_Hidden_Clinical_Phenotypes_With_Dr_Heather_G._Allore.mp3?dest-id=1862984",16954078,1054,"2022-09-01T15:00:00Z",{"_59":275,"_44":276,"_46":277,"_42":278,"_73":74,"_75":279,"_77":280,"_79":281,"_81":82},"c6b4fe40-7520-4c26-b84a-00e2a383abd7","Use of Run-in Periods in Randomized Trials With Dr Armitage","use-of-run-in-periods-in-randomized-trials-with-dr-armitage","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Use_of_Run-in_Periods_in_Randomized_Trials_With_Dr_Armitage.mp3?dest-id=1862984",46823597,1169,"2022-05-05T06:30:00Z",{"_59":283,"_44":284,"_46":285,"_42":286,"_73":74,"_75":287,"_77":288,"_79":289,"_81":82},"561d687d-6d9f-4fdb-bc0a-946fba476924","Regression Discontinuity Study Design to Estimate Observational Differences With Dr Maciejewski","regression-discontinuity-study-design-to-estimate-observational-differences-with-dr-maciejewski","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Regression_Discontinuity_Study_Design_to_Estimate_Observational_Differences_With_Dr_Maciejewski.mp3?dest-id=1862984",17278348,1074,"2022-04-07T15:00:00Z",{"_59":291,"_44":292,"_46":293,"_42":294,"_73":74,"_75":295,"_77":296,"_79":297,"_81":82},"c4a7fe83-449f-40ce-8ecc-ea660dfa4ac3","Case-Control Studies: Using \"Real-world\" Evidence to Assess Association, With Dr Irony","case-control-studies-using-real-world-evidence-to-assess-association-with-dr-irony","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Case-Control_Studies_Using_Real-world_Evidence_to_Assess_Association_With_Dr_Irony.mp3?dest-id=1862984",55579853,1387,"2021-12-02T16:00:00Z",{"_59":299,"_44":300,"_46":301,"_42":302,"_73":74,"_75":303,"_77":304,"_79":305,"_81":82},"913bd796-6eb4-4f23-ba79-becce2a0e1d2","Equipoise in Research—Integrating Ethics and Science in Human Research","equipoise-in-researchintegrating-ethics-and-science-in-human-research","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Equipoise_in_ResearchIntegrating_Ethics_and_Science_in_Human_Research.mp3?dest-id=1862984",52388749,1308,"2021-10-07T15:00:00Z",{"_59":307,"_44":308,"_46":309,"_42":310,"_73":74,"_75":311,"_77":312,"_79":313,"_81":82},"77061b99-7c8c-48d8-8d21-65565f14397b","Bayesian Analysis: Using Prior Information to Interpret the Results of Clinical Trials","bayesian-analysis-using-prior-information-to-interpret-the-results-of-clinical-trials","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Bayesian_Analysis__Using_Prior_Information_to_Interpret_the_Results_of_Clinical_Trials.mp3?dest-id=1862984",33067289,1651,"2021-09-02T15:00:00Z",{"_59":315,"_44":316,"_46":317,"_42":318,"_73":74,"_75":319,"_77":320,"_79":321,"_81":82},"bcb1b7c9-668c-44e1-a9c1-b25958c58cad","Cost-effectiveness Analysis for Clinicians","cost-effectiveness-analysis-for-clinicians","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Understanding_Cost-effectiveness_Analysis.mp3?dest-id=1862984",17716163,1101,"2021-08-05T15:00:00Z",{"_59":323,"_44":324,"_46":325,"_42":326,"_73":74,"_75":327,"_77":328,"_79":329,"_81":82},"7d973d53-3944-4a2a-a16c-c452df0e90ac","Multiple Comparison Procedures from the JAMA Guide to Statistics and Methods","multiple-comparison-procedures-from-the-jama-guide-to-statistics-and-methods","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Multiple_Comparison_Procedures_from_the_JAMA_Guide_to_Statistics_and_Methods.mp3?dest-id=1862984",21974198,1367,"2021-03-04T16:00:00Z",{"_59":331,"_44":332,"_46":333,"_42":334,"_73":74,"_75":335,"_77":336,"_79":337,"_81":82},"3b48e0bf-5036-4d41-87ad-99e8908bc3b3","Logistic Regression—What It Is and How to Use It in Clinical Research","logistic-regressionwhat-it-is-and-how-to-use-it-in-clinical-research","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Logistic_RegressionWhat_It_Is_and_How_to_Use_It_in_Clinical_Research.mp3?dest-id=1862984",39389377,1967,"2021-01-07T16:00:00Z",{"_59":339,"_44":340,"_46":341,"_42":342,"_73":74,"_75":343,"_77":344,"_79":345,"_81":82},"bcff3df6-0aec-4c92-941c-4f8e332a2e24","Randomization in Clinical Trials from the JAMA Guide to Statistics and Methods","randomization-in-clinical-trials-from-the-jama-guide-to-statistics-and-methods","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Randomization_in_Clinical_Trials_from_the_JAMA_Guide_to_Statistics_and_Methods.mp3?dest-id=1862984",22397812,1394,"2020-12-03T16:00:00Z",{"_59":347,"_44":348,"_46":349,"_42":350,"_73":74,"_75":351,"_77":352,"_79":353,"_81":82},"dfcb4210-c2ec-46b5-9720-db0fa5e7926c","The Stepped-Wedge Clinical Trial: Evaluation by Rolling Deployment","the-stepped-wedge-clinical-trial-evaluation-by-rolling-deployment","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/The_Stepped-Wedge_Clinical_Trial__Evaluation_by_Rolling_Deployment.mp3?dest-id=1862984",18483407,1087,"2020-09-03T15:00:00Z",{"_59":355,"_44":356,"_46":357,"_42":358,"_73":74,"_75":359,"_77":360,"_79":361,"_81":82},"6e982aec-a377-4264-8663-6d61001c85fc","Minimal Clinically Important Difference: Defining What Really Matters to Patients","minimal-clinically-important-difference-defining-what-really-matters-to-patients","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Pragmatic_TrialsPractical_Answers_to__Real-world__Questions.mp3?dest-id=1862984",12336339,703,"2020-08-06T15:00:00Z",{"_59":363,"_44":364,"_46":365,"_42":366,"_73":74,"_75":367,"_77":368,"_79":369,"_81":82},"5dcf3301-15c1-44e2-8a02-2fa07a14c69d","Sample Size Calculation for a Hypothesis Test With Dr Lynne Stokes","sample-size-calculation-for-a-hypothesis-test-with-dr-lynne-stokes","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Sample_Size_Calculation_for_a_Hypothesis_Test_with_Dr_Lynne_Stokes.mp3?dest-id=1862984",11838218,734,"2020-07-02T15:00:00Z",{"_59":371,"_44":372,"_46":373,"_42":374,"_73":74,"_75":375,"_77":376,"_79":377,"_81":82},"d3c706a9-4fe8-407d-9f75-baa736ab0f1a","Pragmatic Trials: Practical Answers to \"Real-world\" Questions With Harold C. Sox, MD","pragmatic-trials-practical-answers-to-real-world-questions-with-harold-c-sox-md","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Pragmatic_Trials__Practical_Answers_to__Real-world__Questions_With_Harold_C._Sox_MD.mp3?dest-id=1862984",20485983,1274,"2020-06-25T15:00:00Z",{"_59":379,"_44":380,"_46":381,"_42":382,"_73":74,"_75":383,"_77":384,"_79":385,"_81":82},"c97fde83-1aca-44f0-a060-e4425ff8606a","Cluster Randomized Trials: Evaluating Treatments Applied to Groups With William J. Meurer, MD","cluster-randomized-trials-evaluating-treatments-applied-to-groups-with-william-j-meurer-md","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Cluster_Randomized_Trials__Evaluating_Treatments_Applied_to_Groups_With_William_J._Meurer_MD.mp3?dest-id=1862984",22749004,1419,"2020-05-07T15:00:00Z",{"_59":387,"_44":388,"_46":389,"_42":390,"_73":74,"_75":391,"_77":392,"_79":393,"_81":82},"b3aed250-a38d-455b-b96b-013414be36b4","Noninferiority Trials: Is a New Treatment Almost as Effective as Another? with Dr Amy Kaji","noninferiority-trials-is-a-new-treatment-almost-as-effective-as-another-with-dr-amy-kaji","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Noninferiority_Trials__Is_a_New_Treatment_Almost_as_Effective_as_Another__with_Dr_Amy_Kaji.mp3?dest-id=1862984",10545217,652,"2020-02-06T16:00:00Z",{"_59":395,"_44":396,"_46":397,"_42":398,"_73":74,"_75":399,"_77":400,"_79":401,"_81":82},"4c6d3a7e-e29a-4d73-94be-9da6adb5f4cc","JAMA Guide to Statistics and Methods","jama-guide-to-statistics-and-methods","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/JAMA_Guide_to_Statistics_and_Methods.mp3?dest-id=1862984",13270100,823,"2019-12-05T14:00:00Z","dataUpdateCount",1,"dataUpdatedAt",1771949384957,"error","errorUpdateCount","errorUpdatedAt","fetchFailureCount","fetchFailureReason","fetchMeta","isInvalidated","status","success","fetchStatus","idle","queryKey",[419,420,14],"podcasts","detail","queryHash","[\"podcasts\",\"detail\",\"0d324d20-779a-0138-ede8-0acc26574db2\"]",{"_24":25,"_26":424,"_417":426,"_421":428},{"_28":425,"_402":403,"_404":25,"_406":-5,"_407":6,"_408":6,"_409":6,"_410":-5,"_411":-5,"_412":35,"_413":414,"_415":416},"

Jody D. Ciolino, PhD, Northwestern University, Feinberg School of Medicine discusses Factorial Clinical Trial Designs with JAMA Statistical Editor Roger J. Lewis, MD, PhD

Related Content:

",[427,420,16],"episodeShowNotes","[\"episodeShowNotes\",\"detail\",\"153652b3-b08a-43b3-9999-1d6665650485\"]","actionData","errors"]

Factorial Clinical Trial Designs With Dr Ciolino

Episode Description

Never lose your place, on any device